Akso Health Group (NASDAQ:AHG) versus PetMed Express (NASDAQ:PETS) Critical Survey

Akso Health Group (NASDAQ:AHG) and PetMed Express (NASDAQ:PETS) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Insider & Institutional Ownership

1.2% of Akso Health Group shares are owned by institutional investors. Comparatively, 73.3% of PetMed Express shares are owned by institutional investors. 1.1% of PetMed Express shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Akso Health Group and PetMed Express”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akso Health Group	$2.41 million	108.41	-$9.46 million	N/A	N/A
PetMed Express	$281.06 million	0.22	-$7.46 million	$0.01	306.00

PetMed Express has higher revenue and earnings than Akso Health Group.

Volatility & Risk

Akso Health Group has a beta of -0.65, indicating that its share price is 165% less volatile than the S&P 500. Comparatively, PetMed Express has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.

Profitability

This table compares Akso Health Group and PetMed Express’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Akso Health Group	N/A	N/A	N/A
PetMed Express	0.14%	0.37%	0.23%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Akso Health Group and PetMed Express, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akso Health Group	0	0	0	0	0.00
PetMed Express	1	0	0	0	1.00

PetMed Express has a consensus target price of $3.20, indicating a potential upside of 4.58%. Given PetMed Express’ stronger consensus rating and higher possible upside, analysts plainly believe PetMed Express is more favorable than Akso Health Group.

Summary

PetMed Express beats Akso Health Group on 10 of the 11 factors compared between the two stocks.

About Akso Health Group

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

About PetMed Express

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.